Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been assigned a consensus rating of “Moderate Buy” from the fifteen analysts that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $24.86.

A number of analysts have commented on PRVA shares. Royal Bank of Canada reaffirmed an “outperform” rating and set a $28.00 target price on shares of Privia Health Group in a report on Wednesday, August 14th. Evercore ISI reduced their price objective on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Finally, Robert W. Baird raised their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th.

Privia Health Group Trading Up 0.6 %

Shares of NASDAQ:PRVA opened at $18.08 on Monday. The stock has a fifty day simple moving average of $19.46 and a two-hundred day simple moving average of $18.52. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $24.35. The stock has a market capitalization of $2.16 billion, a price-to-earnings ratio of 120.53, a PEG ratio of 4.24 and a beta of 0.77.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02). The business had revenue of $422.30 million during the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.06 EPS. As a group, equities research analysts predict that Privia Health Group will post 0.16 EPS for the current year.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 14.20% of the stock is owned by company insiders.

Institutional Trading of Privia Health Group

Several large investors have recently bought and sold shares of PRVA. Norges Bank acquired a new stake in shares of Privia Health Group during the 4th quarter worth about $27,959,000. First Light Asset Management LLC acquired a new stake in shares of Privia Health Group during the first quarter valued at about $21,620,000. Millennium Management LLC raised its stake in shares of Privia Health Group by 2,994.2% in the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after acquiring an additional 1,101,730 shares during the period. Riverbridge Partners LLC lifted its holdings in shares of Privia Health Group by 17.5% in the 1st quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company’s stock worth $105,779,000 after acquiring an additional 804,304 shares during the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of Privia Health Group by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company’s stock worth $259,740,000 after acquiring an additional 274,345 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.